FDA Direct: The Power of Real-Time Clinical Trials
Commissioner Makary joins FDA’s Chief AI Officer Jeremy Walsh and two industry leaders to discuss the advancement of real-time clinical trials, which can accelerate drug development and help the agency make decisions more efficiently.
▶︎
FDA Direct: Combating Rare Diseases at the FDA
▶︎
Advancing Real-Time Clinical Trials
▶︎
FDA Direct: Priorities for a New FDA
▶︎
FDA Direct: Who Buys the Spin — Hook, Line and Sinker?
▶︎
Adeno-Associated Virus-Mediated Gene Therapy - Advances, Immune Challenges, and Research Innovations
▶︎
ClinicalTrials.gov: Essentials for Academic Medical Centers – Pre-recorded Training Video
▶︎
FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)
▶︎
FDA Direct: No One Think It's a Good Idea for Kids to Consume Petroleum Products
▶︎
FDA Direct - Special Edition of FDA Direct
▶︎
FDA Direct: An Eye on CDRH: Regulating for a New Era of Medical Devices
▶︎
FDA Direct with Dr. Martin Makary, FDA Commissioner
▶︎
FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers
▶︎
OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products
▶︎
FDA Direct: Citrus Regs, Natural Dye Pledges, and Hidden Opioids
▶︎
CDRH Patient Education Program: Patients as Advisors in Medical Device Clinical Studies
▶︎
FDA Grand Rounds - Clinical Omics Biomarker Discovery and Validation in Precision Medicine
▶︎
FDA Direct: Dramatically lowering drug prices for Americans
▶︎
FDA Direct: Faster Reviews, Food Dye Wins and Protecting American DNA
▶︎
VRBPAC -- May 28 Meeting
▶︎